There is limited information about the determinants of voluntary pregnancy termination (VPT) among women with HIV in the current context of wide access to highly active antiretroviral therapy (HAART). To investigate this issue, we analysed the characteristics of a series of VPTs which occurred in an ongoing observational national study of pregnant women with HIV between 2002 and 2008. Sixty-three cases of VPT were compared with 334 pregnancies not ending in a VPT concurrently reported from the same centres. VPTs showed significant associations with unplanned pregnancy (odds ratio [OR]: 24.3; 95% confidence interval [CI]: 5.8Á101.2), previous pregnancies reported to the study (OR: 2.5; 95% CI: 1.30Á4.82), lower CD4 counts (270 vs. 420 cells/mm 3 ), and HIV-infected current partner (OR: 1.88; 95% CI: 0.97Á3.63).
There is limited information about the determinants of voluntary pregnancy termination (VPT) among women with HIV in the current context of wide access to highly active antiretroviral therapy (HAART). To investigate this issue, we analysed the characteristics of a series of VPTs which occurred in an ongoing observational national study of pregnant women with HIV between 2002 and 2008. Sixty-three cases of VPT were compared with 334 pregnancies not ending in a VPT concurrently reported from the same centres. VPTs showed significant associations with unplanned pregnancy (odds ratio [OR]: 24.3; 95% confidence interval [CI]: 5.8Á101.2), previous pregnancies reported to the study (OR: 2.5; 95% CI: 1.30Á4.82), lower CD4 counts (270 vs. 420 cells/mm 3 ), and HIV-infected current partner (OR: 1.88; 95% CI: 0.97Á3.63).
Our data indicate that there is still the need to improve pregnancy planning among women with HIV, and strongly suggest that interventions aimed at improving pregnancy planning might also reduce the occurrence of VPT. Women with low CD4 counts and those with an HIV-infected partner represent two groups that should receive particular attention in preventive strategies.
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Background and methods
Following the introduction of highly active antiretroviral therapy (HAART), several studies have described the rates and outcomes of pregnancy among women with HIV (Cotter, Garcia, Duthely, Luke, & O'Sullivan, 2006; European Collaborative Study, 2005; Kourtis, Schmid, Jamieson, & Lau, 2007; Szyld et al., 2006; Townsend, Cortina-Borja, Peckham, & Tookey, 2008; Tuomala et al., 2005; Watts et al., 2007) , but there is limited information about the determinants of voluntary pregnancy termination (VPT) among women with HIV in recent years. Defining whether particular clinical or demographic characteristics are associated with this event may be of interest for epidemiological purposes and for the design and implementation of preventive measures.
In order to investigate this issue, we studied the characteristics of the VPT reported during the last seven years to the National Program on Surveillance on Antiretroviral Treatment in Pregnancy, an ongoing observational national study which evaluates different outcomes among pregnant women with HIV (Floridia et al., 2006) . The study is structured as a prospective cohort, with reporting recommended before pregnancy outcome. Retrospective reports are also allowed, but represent less than 20% of total cases in the project. Laboratory and clinical data (including co-infections with hepatitis viruses and details on antiretroviral treatment) are collected from hospital records of Obstetrics, Infectious Diseases and Paediatrics departments following women's consent. Information on past and recent substance use and on the HIV status of current partner is based *Corresponding author. Email: floridia@iss.it on the women's reports. It is estimated that the study collects no less than 50% of all deliveries from HIVinfected mothers occurring in the country (Girardi et al., 2006) . Both study protocol and patients' information sheet received Ethics approval. For the present analysis, we considered all the centres that reported at least one VPT from December 2001 (study start) to September 2008, and compared the pregnancies ending in a VPT with all the pregnancies with a first trimester assessment, concurrently reported from the same centres, that did not end in a VPT. Categorical data were compared using the x 2 test and quantitative data by the MannÁWhitney test for independent samples. P values below 0.05 were considered as significant. Data were analysed using the SPSS software, version 13.0.1 (SPSS Inc., Chicago, USA).
Results
Overall, 71 cases of VPT and 438 pregnancies not ending in a VPT were reported from 14 centres. Following exclusion of eight cases of VPT associated with structural, genetic or chromosomal abnormalities and of 104 pregnancies not ending in a VPT associated with either first trimester spontaneous abortion (n053) or presentation after first trimester of pregnancy (n 051), 63 cases of VPT not motivated by any of the above abnormalities were compared with 334 pregnancies that presented within the first trimester, had a normal ultrasonographic assessment at this time, and did not end in a VPT.
The main characteristics of pregnancies with and without VPT are shown in Table 1 . No significant differences between the two groups were observed for maternal age, time since HIV diagnosis, HIV viral load, preconception counselling, nationality, coinfection with hepatitis viruses, recent substance use, history of intravenous drug use, history of sexually transmitted diseases (STDs), antiretroviral experience and treatment status at conception.
In addition, no differences in VPT rate were observed between women with and without a previous history of VPT. Conversely, VPT rate was significantly higher in those women who had at least another pregnancy reported to the project (odds ratio [OR]: 2.5; 95% confidence interval [CI]: 1.30Á4.82; p00.005), had not planned current pregnancy (OR: 24.3; 95% CI: 5.8Á101.2; p B0.001), and had more advanced HIV disease, as indicated by lower CD4 cell counts (median: 270 vs. 420, p00.011). Women with an HIV-infected partner were slightly more likely to have a VPT, although this was only borderline significant (OR: 1.88; 95% CI: 0.97Á3.63; p 00.057) (Table 1) .
Discussion
Different studies conducted before the year 2002 reported a reduction in VPT among women with HIV following introduction of HAART in clinical practice (Bongain et al., 2002; Massad et al., 2004; van Benthem et al., 2000) . The main objective of our analysis was to define which factors are currently associated with an occurrence of VPT among women with HIV, in a time period fully representative of the recent changes introduced in antiretroviral treatment. Our results show some similarities with the findings of Bongain et al., particularly with the data they collected after 1994, with no association with age or ethnic origin, and with a higher risk of VPT associated with previous pregnancies, disease status (expressed in our study by CD4 count), and HIV infection of the partner. In our study, however, the risk of current VPT did not increase in women with a past history of VPT, and was not related to route of transmission. Such discrepancies may be due to different characteristics of the two populations studied, but might also reflect temporal trends in population demographics (progressive substitution of intravenous drug users with heterosexual women) or in decision making among pregnant women with HIV (increasingly positive attitude towards pregnancy). We also cannot exclude that the discrepancies observed between this study and others are due to the small number of terminations in this study and limited statistical power. It is important to note that the objective of our study was only to define the characteristics associated with VPT, and our data do not allow to estimate precisely the rate of VPT among women with HIV. Specifically designed studies should assess this rate and possible temporal trends in recent years.
Our analyses suggest that women with more advanced HIV disease and with an HIV-infected partner are more likely to have a VPT. Although we were unable to evaluate the role of marital status, which was significantly associated with VPT in other studies (Bongain et al., 2002; Massad et al., 2004) , our data confirm that even in recent years the clinical conditions of the mother and the HIV status of the partner remain two important factors for decision making in pregnant women with HIV. The association found between VPT and previous but recent pregnancies, together with the observed low rate of counselling, might reflect sustained poor pregnancy planning and inadequate preconception care in a subgroup of women that undergo repeated unplanned pregnancies.
In this particular group of women, it could be reasonable to discuss, based on an individual assessment of risks and benefits, the potential use of a long AIDS Care 51 acting reversible contraceptive, even if there is currently uncertainty on the best option available within this category for women with HIV (Heikinheimo & La¨hteenma¨ki, 2009; Stringer et al., 2007) .
In summary, although the rate of VPT may currently be lower compared to the pre-HAART era because of the improvements in HIV therapeutics and in prevention of vertical transmission, our data clearly indicate that there is still the need to improve preconception counselling and pregnancy planning among women with HIV. It is reasonable to assume that additional investigations and interventions on the factors associated with unplanned pregnancy might further reduce the occurrence of VPT among these women. Women with low CD4 count and those with an HIV-infected partner represent two groups that should receive particular attention. 
